The US ACL Graft Market was valued at $26.69 Million in 2024 and projected to reach to $35.99 Million by 2029, representing a compound annual growth rate of 6.2%. The US ACL Graft Market is positioned for steady growth through 2029, supported by a mature healthcare infrastructure and high incidence of ACL injuries among athletes and active populations.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
The US ACL Graft Market is valued at $26.69 million in 2024, with projected growth to $35.99 million by 2029, demonstrating steady expansion in the orthopedic sector.
The US market exhibits a CAGR of 6.2% through 2029, driven by increasing ACL reconstruction procedures and adoption of advanced graft technologies in American healthcare facilities.
Advanced orthopedic infrastructure, state-of-the-art surgical facilities, and established clinical protocols position the US as a mature and well-developed market for ACL grafts.
High prevalence of sports-related injuries, robust reimbursement frameworks, and strong healthcare spending support consistent demand for ACL reconstruction procedures across the US.
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | FALLS (Non-Sports Injury) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 7.2% from 2024 to 2029 |
| Largest Segment | HOSPITALS & AMBULATORY SURGERY CENTERS (End User) |
| Market Size Base Year (Billions) | ~USD 0.13 (2024) |
| Revenue Forecast (Billions) | ~USD 0.18 (2029) |
| Segments Covered | Type Of Acl Surgery, Age Group, Gender, Injury Type, Sports Injury, Non-Sports Injury, End User |
7 segment dimensions are covered across the global market.
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| HOSPITALS & ASCS | 41.69 | 43.61 | 45.88 | 48.49 | 51.57 | 55.14 | 59.23 | 63.84 | 6.8 |
| SPECIALTY CENTERS | 8.11 | 8.37 | 8.69 | 9.06 | 9.51 | 10.04 | 10.64 | 11.32 | 5.4 |
| TOTAL | 49.79 | 51.98 | 54.57 | 57.55 | 61.08 | 65.18 | 69.87 | 75.16 | 6.6 |
The US ACL Graft Market is valued at $26.69 million in 2024, reflecting strong demand for ACL reconstruction procedures across the country.
The US ACL Graft Market is projected to reach $35.99 million by 2029, growing at a compound annual growth rate of 6.2%.
Growth in the US market is driven by high prevalence of sports-related ACL injuries, advanced orthopedic surgical infrastructure, strong insurance reimbursement, and increasing adoption of premium graft materials.
The US market utilizes autografts, allografts, and synthetic grafts, with increasing preference for premium options that offer superior biocompatibility and long-term outcomes.
The US represents the largest and most mature segment within North America, characterized by advanced healthcare infrastructure, higher surgical volumes, and greater adoption of innovative graft technologies.
To determine the current size of the ACL graft market, this study engaged in four main activities. A comprehensive study was conducted using secondary research methods to gather data about the market, its parent market, and its peer markets. The next stage involved conducting primary research to confirm these conclusions, assumptions, and sizing with industry experts throughout the value chain. A combination of top-down and bottom-up methods was used to assess the overall market size. The market sizes of segments and subsegments were then estimated using data triangulation techniques and market breakdown.
The four steps involved in estimating the market size are
Within the secondary data collection process, a range of secondary sources were reviewed so as to identify and gather data for this study, including regulatory bodies, databases (like D&B Hoovers, Bloomberg Business, and Factiva), white papers, certified publications, articles by well-known authors, annual reports, press releases, and investor presentations of companies.
A thorough method was used in the primary research phase, which involved interviewing a wide range of sources from the supply and demand sides. The purpose of these interviews was to obtain the quantitative and qualitative information needed to put up this report. The main sources of information were industry experts from both core and related sectors, as well as preferred manufacturers, distributors, suppliers, pioneers in technology, and organizations involved in every aspect of this industry's value chain. A variety of primary respondents, including important industry stakeholders, subject-matter experts, C-level executives from crucial market companies, and industry advisers, were carefully questioned in-depth. The goal was to gather and validate important qualitative and quantitative insights and to conduct a thorough assessment of future possibilities.

Note 1: Others include sales, marketing, and product managers.
Note 2: Tiers of companies are defined based on their total revenue. As of 2023, Tier 1 = >USD 5 billion, Tier 2 = USD 500 million to USD 5 billion, and Tier 3 = < USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
|
COMPANY NAME |
DESIGNATION |
|
MTF Biologics (US) |
Area Sales Manager |
|
AlloSource (US) |
Area Account Manager |
|
RTI Surgical (US) |
Consultant |
Both top-down and bottom-up approaches were used to estimate and validate the total size of the ACL graft market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

After arriving at the overall market size applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Allograft anterior cruciate ligament reconstruction is a surgical intervention designed to repair a tear in the anterior cruciate ligament (ACL) of the knee, utilizing donor tissue for grafting.
A strip of donated tendon is used during allograft anterior cruciate ligament reconstruction surgery to strengthen the injured ACL. Donated tendons are obtained from deceased individuals who gave their permission for their tendons to be used in a way that benefits others.
With the given market data, MarketsandMarkets offers customizations to meet the company’s needs. The following customization options are available for the report:
Further breakdown of the ACL graft market into specific countries/regions in Europe, Asia Pacific, Latin America, Middle East & Africa, and GCC Countries.
Detailed analysis and profiling of additional market players (up to Five), inclusive of:
Note: Some companies are privately owned, and their revenues are unavailable in the public domain. Hence, revenues for privately owned companies will not be included in their profile. In addition, company developments that are not reported in the public domain will not be included.
Full forecast, segment splits, and company analysis for all ACL Graft Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report